Navigation Links
Researchers detail the migrations of the wood wasp Sirex noctilio
Date:11/21/2012

In order to find out about its migrations, various research centres in South Africa, Sweden, Canada, Chile, Australia, Spain, Argentina and Switzerland have conducted research detailing its routes and expansion periods. A significant new fact has emerged and it is that the wasps returning to Europe from Chile and South Africa have undergone a genetic micro-evolution which makes them more resistant to their natural European enemy, a nematode that sterilises them.

The Sirex noctilio wasp is regarded as a secondary pest in Europe because in this geographical area there is a natural enemy preventing its spread on a large scale. It is a nematode that gets into the wasp's genital organs and sterilizes it. However, the wasp is a pest of great importance in the zones it has migrated to like Australia, South America and South Africa, where it does not have to contend with this natural enemy.

In the countries where it has been accidentally introduced, the insect can even kill a tree, because when the females lay their eggs inside the trunk, they also release a fungus and a toxic mucoid substance which kills off the specimen. As an example of its devastating effect, one can cite that in Australia it succeeded in killing 40% of the pine trees after it was introduced halfway through the last century.

The researchers want to make it quite clear that in Europe one must remain vigilant in the management of the Sirex noctilio. In the genetic analyses carried out, it has been discovered that samples originating in Chile and South Africa and which have been detected in Switzerland have undergone a genetic micro-evolution. This genetic modification makes them more resistant to the nematode that can render them sterile; so their capacity to reproduce and spread increases considerably. The specimens displaying this microevolution have an unknown genetic origin, even though specialists believe that they may have originated in Asia or North Africa.

Migratory routes and times

By combining molecular studies, experts have managed to establish the migratory routes of this species. According to their conclusions, the first presence of the wasp outside its native habitat was recorded in New Zealand in 1900, and the next one was recorded in Australia in 1961. Its advance continued from Europe and Oceania towards South America, where it settled in Uruguay in 1980, Argentina in 1985, and Chile in 2001. From the Southern Cone and Oceania, the wasp reached South Africa in 1994. The next migration took place from Europe and South America towards the United States and Canada where it settled in 2004 and 2005, respectively.

To conduct this research, the researchers have genetically studied 500 specimens of the Sirex noctilio. The specimens captured on the Iberian Peninsula were analysed by the Basque Institute for Agricultural Research and Development, Neiker-Tecnalia.


'/>"/>
Contact: Irati Kortabitarte
i.kortabitarte@elhuyar.com
34-943-363-040
Elhuyar Fundazioa
Source:Eurekalert

Related biology news :

1. Researchers identify a simple way to precipitate phosphorus from the wastewater of a pulp mill
2. Researchers decode birch tree genome sequence for the first time
3. Researchers develop guidebook for promoting healthy lifestyles among Hispanic populations
4. Researchers study links between conflict and fisheries in East Africa
5. A class of RNA molecules protects germ cells from damage, Penn vet researchers show
6. Researchers sequence swine genome, discover associations that may advance animal and human health
7. Researchers uncover some good news for BCs troubled salmon populations
8. Researchers use GPS tracking to monitor crab behavior
9. Researchers tap into CO2 storage potential of mine waste
10. Undersea gas leaks off Israels coast are discovered by University of Haifa researchers
11. Researchers discover 2 genetic flaws behind common form of inherited muscular dystrophy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2017)... MELBOURNE , Australia , March ... clinical study data at the prestigious World Lung Imaging ... Dr. Andreas Fouras , was invited to deliver ... and pulmonary medicine. This globally recognised event brings together ... and share the latest developments in lung imaging. ...
(Date:3/6/2017)... MATEO, Calif. , March 6, 2017 /PRNewswire/ ... marketing and sales technology, today announced Predictive Sales ... solution for infusing actionable sales intelligence into Salesforce. ... to automatically enable their sales organizations with deep ... messages that allow for intelligent engagement. Predictive Sales ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... -- NetworkNewsWire Editorial Coverage  ... Cancer remains one of the ... care systems, in terms of costs and resources. However, as ... development of innovative and efficient therapies that demonstrate higher chances ... of cancer treatments, a growing number of patients receiving immuno-oncology ...
(Date:3/22/2017)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today announced a major research ... GSK to generate genetic sequence data from the 500,000 volunteer ... researchers to gain valuable insights to support advances in the ... and life threatening diseases. ... Genetic evidence has revolutionized scientific discovery ...
(Date:3/22/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... ), a clinical-stage pharmaceutical company focused on ... today that Dr. Miriam Kidron , Oramed,s ... "Oral Insulin for Diabetes Treatment: Bypassing the Roadblock," ... Peptide Therapeutics (OPT) Boston Conference in Cambridge, ...
Breaking Biology Technology: